Category Archives: People

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEEDHAM, Mass., July 01, 2026 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on June 30, 2026, the Compensation Committee of Candel’s Board of Directors (the Board) granted to one new […]

Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America

Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has formally filed a complete membership application with the Personal Care Products Council (PCPC). The submission encompasses all requisite corporate qualifications, raw material compliance documentation, and product safety materials, all […]

The 8th Tourism Industry Development Conference in Heilongjiang Province is about to inaugurate

JIXI, China, July 01, 2026 (GLOBE NEWSWIRE) — Scheduled for July 8-9, the 8th Tourism Industry Development Conference in Heilongjiang Province will be unveiled in Jixi City, a renowned eco-tourism destination. Centred on the theme of “Integration, Innovation, and Opportunity” and the guiding principles of simplicity, safety, and excellence, the conference aims to establish robust […]

International Beauty Brand SIMETRA Launches its First AI Smart Skin-Detection Mirror and Art-Infused Hair brush

HongKong, China, June 30, 2026 (GLOBE NEWSWIRE) — International beauty brand SIMETRA has announced the launch of its first AI Smart Skin-Detection Mirror and Art-Infused Hair Brush collection, bringing together advanced skin analysis technology, award-winning product design, and artistic craftsmanship for consumers worldwide. SIMETRA is a high-tech enterprise focused on helping users achieve beauty instantly, […]

60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue

Independent DSMB identifies no safety concerns and recommends continuation of the clinical trial being conducted at the Icahn School of Medicine at Mount Sinai WASHINGTON, July 01, 2026 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, announced […]

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer’s Association International Conference (AAIC) 2026

NAARDEN, the Netherlands and MIAMI, July 01, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, […]

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

New preclinical data will guide antigen selection for a broadly protective cytomegalovirus vaccine candidate Poster presentation on July 12, 2026, at the International Herpesvirus Workshop 2026 taking place in Montreal, Canada COPENHAGEN, Denmark, July 1, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will […]

Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer

MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced the promotion of Cheng Fang, Ph.D., to Chief Scientific Officer. Dr. Fang, […]